Detalhe da pesquisa
1.
SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.
J Immunol
; 207(3): 878-887, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34301847
2.
SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals.
J Immunol
; 206(1): 109-117, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33208457
3.
The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization.
J Biol Chem
; 296: 100536, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33716040
4.
Reply to Lassaunière: On the functional characterization of the Y453F RBD variant found in cluster 5 SARS-CoV-2.
J Biol Chem
; 297(5): 101241, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735911
5.
Structure-Based Design of a New Scaffold for Cell-Penetrating Peptidic Inhibitors of the Histone Demethylase PHF8.
Chembiochem
; 18(14): 1369-1375, 2017 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28430394
6.
Intersubunit bridge formation governs agonist efficacy at nicotinic acetylcholine α4ß2 receptors: unique role of halogen bonding revealed.
J Biol Chem
; 287(6): 4248-59, 2012 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22170047
7.
DNA binding by the plant-specific NAC transcription factors in crystal and solution: a firm link to WRKY and GCM transcription factors.
Biochem J
; 444(3): 395-404, 2012 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22455904
8.
The alpha/B.1.1.7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 mice.
Elife
; 102021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34821555
9.
Functional Effects of Receptor-Binding Domain Mutations of SARS-CoV-2 B.1.351 and P.1 Variants.
Front Immunol
; 12: 757197, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34691078
10.
Proteomics-Based Comparative Mapping of the Secretomes of Human Brown and White Adipocytes Reveals EPDR1 as a Novel Batokine.
Cell Metab
; 30(5): 963-975.e7, 2019 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31668873
11.
Structural basis of RNA binding discrimination between bacteriophages Qbeta and MS2.
Structure
; 14(3): 487-95, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16531233
12.
The EndoC-ßH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidates.
Mol Metab
; 8: 144-157, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29307512
13.
Investigating the structural basis of purine specificity in the structures of MS2 coat protein RNA translational operator hairpins.
Nucleic Acids Res
; 30(12): 2678-85, 2002 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12060685
14.
Targeting histone lysine demethylases by truncating the histone 3 tail to obtain selective substrate-based inhibitors.
Angew Chem Int Ed Engl
; 50(39): 9100-3, 2011 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-21919140
15.
The refined structure of a protein catenane: the HK97 bacteriophage capsid at 3.44 A resolution.
J Mol Biol
; 334(5): 885-99, 2003 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-14643655
16.
Posttranslational modifications of the histone 3 tail and their impact on the activity of histone lysine demethylases in vitro.
PLoS One
; 8(7): e67653, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23844048
17.
Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor.
FEBS J
; 279(11): 1905-14, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22420752
18.
Identification of catechols as histone-lysine demethylase inhibitors.
FEBS Lett
; 586(8): 1190-4, 2012 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22575654
19.
A leukotriene A4 hydrolase-related aminopeptidase from yeast undergoes induced fit upon inhibitor binding.
J Mol Biol
; 406(1): 120-34, 2011 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-21146536
20.
Enzyme kinetic studies of histone demethylases KDM4C and KDM6A: towards understanding selectivity of inhibitors targeting oncogenic histone demethylases.
FEBS Lett
; 585(12): 1951-6, 2011 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21575637